Raymond James & Associates Organon & Co. Transaction History

Raymond James & Associates

$161 Billion
Q3 2024

A detailed history of Raymond James & Associates transactions in Organon & Co. stock. As of the latest transaction made, Raymond James & Associates holds 102,157 shares of OGN stock, worth $1.5 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

102,157

Previous 324,479 68.52%

Holding current value

$1.5 Million

Previous $6.72 Million 70.91%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 18, 2024	SELL	$18.65 - $23.03 $4.15 Million - $5.12 Million	-222,322 Reduced 68.52%	102,157 $1.95 Million
Q2 2024 Jul 19, 2024	SELL	$17.45 - $21.96 $657,009 - $826,815	-37,651 Reduced 10.4%	324,479 $6.72 Million
Q1 2024 Apr 22, 2024	BUY	$13.78 - $18.8 $270,253 - $368,705	19,612 Added 5.73%	362,130 $6.81 Million
Q4 2023 Jan 16, 2024	SELL	$10.95 - $17.32 $36,047 - $57,017	-3,292 Reduced 0.95%	342,518 $4.94 Million
Q3 2023 Oct 24, 2023	BUY	$16.59 - $23.77 $39,052 - $55,954	2,354 Added 0.69%	345,810 $6 Million
Q2 2023 Jul 25, 2023	BUY	$19.27 - $24.63 $449,935 - $575,085	23,349 Added 7.29%	343,456 $7.15 Million
Q1 2023 Apr 14, 2023	BUY	$21.42 - $32.08 $750,406 - $1.12 Million	35,033 Added 12.29%	320,107 $7.53 Million
Q4 2022 Feb 08, 2023	SELL	$23.31 - $28.61 $314,638 - $386,177	-13,498 Reduced 4.52%	285,074 $7.96 Million
Q3 2022 Oct 25, 2022	BUY	$23.4 - $34.25 $349,993 - $512,277	14,957 Added 5.27%	298,572 $6.99 Million
Q2 2022 Aug 12, 2022	BUY	$31.66 - $38.9 $179,195 - $220,174	5,660 Added 2.04%	283,615 $9.57 Million
Q1 2022 May 11, 2022	SELL	$30.45 - $39.36 $303,373 - $392,143	-9,963 Reduced 3.46%	277,955 $9.71 Million
Q4 2021 Feb 08, 2022	BUY	$28.67 - $37.13 $766,922 - $993,227	26,750 Added 10.24%	287,918 $8.77 Million
Q3 2021 Nov 02, 2021	BUY	$28.63 - $35.64 $787,725 - $980,598	27,514 Added 11.78%	261,168 $8.56 Million
Q2 2021 Aug 11, 2021	BUY	$28.45 - $38.0 $6.65 Million - $8.88 Million	233,654 New	233,654 $7.07 Million

Others Institutions Holding OGN

# of Institutions

791

Shares Held

193M

Call Options Held

1.71M

Put Options Held

865K

View Full List

About Organon & Co.

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.75B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

More about OGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.

Account

Raymond James & Associates Organon & Co. Transaction History